Compare WABC & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WABC | ENOV |
|---|---|---|
| Founded | 1972 | 1995 |
| Country | United States | United States |
| Employees | 627 | N/A |
| Industry | Major Banks | Fluid Controls |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1994 | 2008 |
| Metric | WABC | ENOV |
|---|---|---|
| Price | $58.84 | $21.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $54.00 | $47.38 |
| AVG Volume (30 Days) | 175.0K | ★ 1.1M |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.40 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.36 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | $17.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.93 | $20.55 |
| 52 Week High | $59.25 | $36.82 |
| Indicator | WABC | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 71.76 | 42.45 |
| Support Level | $46.94 | N/A |
| Resistance Level | N/A | $24.08 |
| Average True Range (ATR) | 1.25 | 1.22 |
| MACD | 0.12 | -0.08 |
| Stochastic Oscillator | 91.45 | 17.12 |
Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.